ERBB2 and urinary bladder cancer: Curiously, the incidence of HER2 overexpression in bladder cancer (12.4%) is even higher than that found in breast carcinomas (10.5%), where it is associated with tumour aggressiveness, prognosis and responsiveness to therapy [81].